MLchartDataset catalogue

BEACOPP

Term · Oncology and biomedicine · MLC-T-ONC-000963

An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called BEACOPP regimen.

Table 1. Record
IdentifierMLC-T-ONC-000963
FieldOncology and biomedicine
ExpansionsBEACOPP regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000963",
  "term": "BEACOPP",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called BEACOPP regimen.",
  "expansions": [
    "BEACOPP regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/beacopp/"
}

Record 3,381 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.